Pre-treatment disease trajectories in severe asthma impact treatment-related outcomes, according to a study by Johannes Martin Schmid, PhD, and colleagues.
A study of US insurance data determined ABPA prevalence among patients with asthma and those with CF and offered insights into testing and treatment patterns.
Chronic cough in severe asthma was associated with worsened asthma control and patient QOL, according to a recent study published in JACI: In Practice.
Researchers have identified four immune response-related hub genes that could act as diagnostic markers and lead to therapeutic targets for severe asthma, according to a study published in the Journal of Asthma. “There is...
When clinicians become patients, they report greater empathy for their patients, understanding fears, uncertainties, and obstacles in the healthcare system.